OPTEX GROUP Company, Limited (TYO:6914)

Sage Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	61,577	62,396	63,447	63,803	58,361	68,204
Market Cap Growth	-12.10%	-1.66%	-0.56%	9.32%	-14.43%	14.03%
Enterprise Value	50,373	52,890	57,532	57,368	48,656	58,683
Last Close Price	1729.00	1728.45	1721.02	1694.44	1521.96	1717.70
PE Ratio	10.06	10.97	13.77	13.43	15.51	48.89
Forward PE	9.66	10.62	12.42	10.76	14.19	31.34
PS Ratio	0.98	0.99	1.13	1.16	1.27	1.96
PB Ratio	1.22	1.25	1.43	1.61	1.65	2.09
P/TBV Ratio	1.26	1.30	1.52	1.73	1.82	2.36
P/FCF Ratio	-	10.25	66.23	122.23	26.87	24.34
P/OCF Ratio	-	8.11	30.03	38.23	18.81	17.52
PEG Ratio	-	1.25	1.25	1.25	1.25	1.25
EV/Sales Ratio	0.80	0.84	1.02	1.05	1.06	1.68
EV/EBITDA Ratio	5.42	5.77	6.98	7.03	7.71	15.94
EV/EBIT Ratio	6.96	7.43	9.24	9.10	10.50	27.96
EV/FCF Ratio	-	8.69	60.06	109.90	22.40	20.94
Debt / Equity Ratio	0.17	0.18	0.24	0.27	0.31	0.20
Debt / EBITDA Ratio	0.92	0.97	1.29	1.33	1.73	1.81
Debt / FCF Ratio	-	1.46	11.11	20.85	5.02	2.37
Asset Turnover	0.89	0.90	0.86	0.91	0.87	0.76
Inventory Turnover	1.41	1.50	1.49	1.92	2.20	2.10
Quick Ratio	1.96	2.00	1.90	1.59	1.50	2.04
Current Ratio	3.45	3.31	3.35	2.56	2.29	2.90
Return on Equity (ROE)	12.81%	12.07%	10.97%	12.66%	11.08%	4.29%
Return on Assets (ROA)	6.38%	6.36%	5.97%	6.51%	5.51%	2.87%
Return on Capital (ROIC)	7.78%	7.82%	7.38%	8.13%	6.77%	3.48%
Return on Capital Employed (ROCE)	13.10%	12.90%	12.10%	14.20%	11.80%	5.80%
Earnings Yield	10.01%	9.12%	7.26%	7.45%	6.45%	2.04%
FCF Yield	-	9.76%	1.51%	0.82%	3.72%	4.11%
Dividend Yield	2.60%	2.31%	2.32%	2.13%	1.97%	1.75%
Payout Ratio	-	25.08%	29.21%	24.64%	29.56%	77.71%
Buyback Yield / Dilution	-0.14%	-0.12%	-0.11%	1.50%	-0.01%	1.05%
Total Shareholder Return	2.50%	2.19%	2.21%	3.63%	1.96%	2.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.